Valuation TG Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-23 EDT			5-day change	1st Jan Change
54.17 ^USD	+1.90%		+0.37%	+81.72%

10-23	TG Therapeutics, Inc. Announces Phase 1 Data Evaluating Azer-Cel in Progressive Multiple Sclerosis At MSToronto2026	CI
10-23	Novartis presents weaker-than-expected relapse data for multiple sclerosis drug remibrutinib	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,488	1,584	2,416	4,320	4,358	7,684	-	-
Change	-	-36.33%	52.51%	78.8%	0.88%	76.31%	-	-
Enterprise Value (EV) ¹	2,257	1,494	2,299	4,384	4,462	7,853	7,336	6,792
Change	-	-33.82%	53.89%	90.74%	1.76%	76%	-6.58%	-7.42%
P/E	-7.22x	-8.1x	190x	201x	10.8x	55.2x	19.1x	15x
PBR	11.5x	27.3x	15.8x	21.7x	-	-	-	-
PEG	-	0.2x	-2x	3x	0x	-0.9x	0x	0.5x
Capitalization / Revenue	372x	569x	10.3x	13.1x	7.07x	8x	5.83x	4.73x
EV / Revenue	337x	536x	9.84x	13.3x	7.24x	8.18x	5.56x	4.18x
EV / EBITDA	-6.55x	-7.76x	110x	104x	36.2x	34.2x	14.1x	11.6x
EV / EBIT	-6.55x	-7.75x	111x	105x	36.2x	36.1x	14x	9.85x
EV / FCF	-7.62x	-8.48x	-73.2x	-108x	-179x	41.3x	11x	9.29x
FCF Yield	-13.1%	-11.8%	-1.37%	-0.93%	-0.56%	2.42%	9.12%	10.8%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.63	-1.46	0.09	0.15	2.77	0.9808	2.831	3.622
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	6.689	2.785	233.7	329	616.3	960.3	1,319	1,626
EBITDA ¹	-344.5	-192.5	20.84	42	123.4	229.5	520.2	585
EBIT ¹	-344.8	-192.8	20.63	41.93	123.3	217.8	524.9	689.7
Net income ¹	-348.1	-198.3	12.67	23.38	447.2	162	445.4	569.1
Net Debt ¹	-231.1	-90.54	-117.4	64.54	103.7	169	-348	-892
Reference price ²	19.00	11.83	17.08	30.10	29.81	54.17	54.17	54.17
Nbr of stocks (in thousands)	130,950	133,915	141,455	143,519	146,198	141,848	-	-
Announcement Date	3/1/22	2/28/23	2/28/24	3/3/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
TG THERAPEUTICS, INC.	55.23x	8.18x	34.22x	-.--%	7.68B
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	32.07x	7.15x	20.25x	1.9%	401.13B
Weighted average by Cap.	35.27x	8.29x	20.42x	1.8%